Axitinib
Back to search| Scientific Name: | Axitinib |
| Brand Name: | Inlyta |
| Company Owner: | Not Available |
| Mechanism Of Action | Axitinib selectively blocks the tyrosine kinase receptors VEGFR-1 (vascular endothelial growth factor receptor) , VEGFR-2, and VEGFR-3. |
| Description of the Drug: | Axitinib is an oral VEGFR and kinase inhibitor used for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy. |
| Protein Data Bank: |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB06626
